Gain Therapeutics (GANX) Leases (2020 - 2025)
Historic Leases for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to $184422.0.
- Gain Therapeutics' Leases fell 3450.41% to $184422.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $184422.0, marking a year-over-year decrease of 3450.41%. This contributed to the annual value of $219715.0 for FY2024, which is 5215.42% down from last year.
- Latest data reveals that Gain Therapeutics reported Leases of $184422.0 as of Q3 2025, which was down 3450.41% from $233200.0 recorded in Q2 2025.
- Over the past 5 years, Gain Therapeutics' Leases peaked at $901042.0 during Q4 2021, and registered a low of $183664.0 during Q1 2025.
- Moreover, its 5-year median value for Leases was $499017.0 (2021), whereas its average is $515764.8.
- Its Leases has fluctuated over the past 5 years, first surged by 7225.7% in 2021, then tumbled by 5218.9% in 2025.
- Quarter analysis of 5 years shows Gain Therapeutics' Leases stood at $901042.0 in 2021, then dropped by 26.76% to $659933.0 in 2022, then plummeted by 30.41% to $459215.0 in 2023, then plummeted by 52.15% to $219715.0 in 2024, then fell by 16.06% to $184422.0 in 2025.
- Its Leases stands at $184422.0 for Q3 2025, versus $233200.0 for Q2 2025 and $183664.0 for Q1 2025.